Campbell will lead studies to measure the impact of PQA’s opioid measures and new opioid prescribing policies, as well as the value of pharmacists in the delivery of patient-centered care. He recently completed his doctorate in pharmaceutical economics, policy and outcomes from the University of Arizona and is passionate about patient-reported outcomes, healthcare quality and safety, and community pharmacy practice.
PQA also has promoted four individuals on its performance measurement, research and operations teams. The staff addition and promotions reflect PQA’s growth and commitment to improve the quality of medication use through measure development, research, education and engagement. The promotions include:
- Lisa Hines, to vice president, performance measurement and operations,
- Matthew Pickering, to senior director, research and quality strategies,
- Melissa Nelson, to director, research and academic affairs, and
- Laurel Glenn, PMP, CPCM, to manager, contracts.
“The addition of Patrick to our team and the promotion of four medication quality experts on our team reflects PQA’s continued growth as a quality measure organization,” Laura Cranston, PQA chief executive officer, said. “We have built the infrastructure to partner with organizations and agencies across the healthcare system to improve patient care and reduce overall healthcare spending through effective quality measurement.”